NYSE:EW Edwards Lifesciences Q3 2026 Earnings Report $85.93 -0.55 (-0.64%) As of 03:20 PM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast Edwards Lifesciences EPS ResultsActual EPSN/AConsensus EPS $0.74Beat/MissN/AOne Year Ago EPSN/AEdwards Lifesciences Revenue ResultsActual RevenueN/AExpected Revenue$1.68 billionBeat/MissN/AYoY Revenue GrowthN/AEdwards Lifesciences Announcement DetailsQuarterQ3 2026Date11/4/2026TimeAfter Market ClosesConference Call DateWednesday, November 4, 2026Conference Call Time5:00PM ETConference Call ResourcesEarnings HistoryCompany Profile Edwards Lifesciences Earnings HeadlinesEdwards Lifesciences to Host Earnings Conference Call on November 4, 2026October 7 at 7:26 AM | finance.yahoo.comEdwards Lifesciences to Host Earnings Conference Call on November 4, 2026October 7 at 7:00 AM | businesswire.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.October 7 at 1:00 AM | Stansberry Research (Ad)Edwards Lifesciences to Host Investor Event in Conjunction With TCTOctober 5 at 9:48 AM | finance.yahoo.comEdwards Lifesciences to Host Investor Event in Conjunction With TCTOctober 5 at 7:00 AM | businesswire.comEdwards Lifesciences Secures FDA Approval for First Expandable Pediatric Heart ValveOctober 2, 2026 | benzinga.comSee More Edwards Lifesciences Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Edwards Lifesciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Edwards Lifesciences and other key companies, straight to your email. Email Address About Edwards LifesciencesEdwards Lifesciences (NYSE:EW) is a medical technology company focused on therapies for structural heart disease and other cardiovascular conditions. The company develops and manufactures heart valve replacement and repair technologies, including transcatheter aortic valve replacement systems, surgical heart valves, transcatheter mitral and tricuspid therapies, and related delivery systems and accessories. Founded in 1958 by engineer Miles “Lowell” Edwards, the company helped pioneer artificial heart valves and has played a significant role in the development of transcatheter valve replacement. Its products are used by hospitals and heart specialists to treat conditions such as aortic stenosis and other heart valve disorders, providing alternatives to traditional open-heart surgery for certain patients. Edwards Lifesciences serves healthcare providers and patients in the United States and international markets across Europe, Asia-Pacific, and other regions. The company is headquartered in Irvine, California, and is led by President and Chief Executive Officer Bernard Zovighian.View Edwards Lifesciences ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Penguin Solutions Is Soaring as AI Memory Demand ExplodesWall Street Is Betting These 3 Beaten-Down Stocks Have More Room to RunLamb Weston’s Turnaround Is Starting to Look RealRPM International’s Dividend King Status Just Got StrongerAI Chip Demand Gives Linde a New Growth CatalystAllient’s Data Center and Defense Momentum Is Raising the StakesInvenTrust’s Sell-Off Opens a Potential Entry Point Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
